2-Sec-Butyl-3-methoxypyrazine
Common Name: |
2-Sec-Butyl-3-methoxypyrazine |
IUPAC Name: |
2-butan-2-yl-3-methoxypyrazine |
Molecular Formula: |
C4H10S2 |
SMILES: |
CCC(C)C1=NC=CN=C1OC |
Inchi: |
1S/C9H14N2O/c1-4-7(2)8-9(12-3)11-6-5-10-8/h5-7H,4H2,1-3H3 |
Inchi Key: |
QMQDJVIJVPEQHE-UHFFFAOYSA-N |
Cas No: |
24168-70-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
122.25 |
Mass (g/mol) |
166.111 |
Molar Refractivity |
37.20 |
Net Charge |
|
HBD |
|
HBA |
0 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
77.60 |
Hetero Atoms |
3 |
Heavy Atoms |
6 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
218.00 to 219.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.1 |
Vapor Density (Air =1) |
5.7 |
Fraction Csp3 |
1.00 |
LogP |
1.999 |
iLOGP |
1.75 |
XLOGP3 |
1.59 |
WLOGP |
1.62 |
MLOGP |
1.82 |
ESOL Log S |
-1.47 |
ESOL Solubility (mg/ml) |
4.16 |
ESOL Solubility (mol/l) |
0.034 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.83 |
Ali Solubility (mg/ml) |
0.18 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.30 |
Silicos-IT Solubility (mg/ml) |
6.13 |
Silicos-IT Solubility (mol/l) |
0.05 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.92 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.807 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.278 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |